Composition and method for the restoration and preservation of transplant organs procured from DCD donors
The present invention provides a perfusion solution comprising specific metabolic agents, antioxidant agents, and membrane stabilizer agents that can help improve preservation, organ viability, and in some cases recover organs that would otherwise being unusable for transplantation. In a further embodiment, the perfusion solution can be used in combination with hypothermic machine perfusion. It has been found that combination of the perfusion solution and hypothermic machine perfusion can help prevent or reduce further damage to the organ and restore the organ's anti-oxidant system, stabilize the cellular cytoskeleton and cellular membranes, inhibit arachidonic acid pathway, provide oncotic support, reduce interstitial edema formation, and help restore energy stores within the organ. As a result, the method can be used to improve the viability of otherwise marginal donor organs.
1. A perfusion solution for restoring and preserving the viability of an organ recovered from a Donation After Cardiac Death (DCD) donor comprising:
a perfusion solution, and wherein the perfusion solution further comprises:
a membrane stabilizer, wherein the membrane stabilizer is present in an amount from 0.1 mM to 10 mM;
a metabolic support agent, wherein the metabolic support agent is present in an amount from 0.1 mM to 15 mM; and
an antioxidant agent selected from the group consisting of beta-carotene, catalase, superoxide dismutase, dimethyl thiourea (DMTU), diphenyl phenylene diamine (DPPD), mannitol, cyanidanol, a-tocopherol, desferoxamine, 6-hydroxy-2,5,7,8-tetramethyl chroman-2-carboxylic acid, and N-acetyl cysteine, and combinations thereof, wherein the antioxidant agent is present in an amount from 0.1 mM to 10 mM.
2. The perfusion solution of claim 1 , wherein the antioxidant agent is selected from the group consisting of α-tocopherol, desferoxamine, 6-hydroxy-2,5,7,8-tetramethyl chroman-2-carboxylic acid, and N-acetyl cysteine.
3. The perfusion solution of claim 1 , wherein the antioxidant agent is a combination of N-acetyl cysteine, desferoxamine, and 6-hydroxy-2,5,7,8-tetramethyl chroman-2-carboxylic acid.
4. The perfusion solution of claim 1 , wherein the membrane stabilizer is selected from the group consisting of calcium, glycine, chlorpromazine, and combinations thereof.
5. The perfusion solution of claim 1 , wherein the metabolic support agent is selected from the group consisting of glucose, glutamine, and combinations thereof.
6. The perfusion solution of claim 1 , wherein the metabolic support agent comprises from about 0.5 mM to 5 mM of glutamine and about 1 mM to 10 mM of glucose.
7. The perfusion solution of claim 1 , wherein the metabolic support agent comprises about 2 mM of glutamine and about 5.5 mM of glucose.
8. The perfusion solution of claim 1 , further comprising an oncotic support agent selected from the group consisting of dextran, polyethylene glycol, albumin, pentastarch, and combinations thereof.
9. The perfusion solution of claim 1 , wherein the antioxidant agent is selected from the group consisting of a-tocopherol, desferoxamine, 6-hydroxy-2,5,7,8-tetramethyl chroman-2-carboxylic acid, and N-acetyl cysteine; the membrane stabilizer is selected from the group consisting of calcium, glycine, chlorpromazine, and combinations thereof; and the metabolic support agent is selected from the group consisting of glucose, glutamine, and combinations thereof.
10. A perfusion solution for restoring and preserving the viability of an organ recovered from a Donation After Cardiac Death (DCD) donor comprising:
a perfusion solution, and wherein the perfusion solution further comprises:
a metabolic support agent, wherein the metabolic support agent is present in an amount from 0.1 mM to 15 mM;
a membrane stabilizer that is selected from the group consisting of calcium, glycine, chlorpromazine, and combinations thereof, wherein the membrane stabilizer is present in an amount from 0.1 mM to 10 mM; and
an antioxidant agent selected from the group consisting of beta-carotene, catalase, superoxide dismutase, dimethyl thiourea (DMTU), diphenyl phenylene diamine (DPPD), mannitol, cyanidanol, a-tocopherol, desferoxamine, 6-hydroxy-2,5,7,8-tetramethyl chroman-2-carboxylic acid, and N-acetyl cysteine, and combinations thereof, wherein the antioxidant agent is present in an amount from 0.1 mM to 10 mM.
11. A perfusion solution for restoring and preserving the viability of an organ recovered from a Donation After Cardiac Death (DCD) donor comprising:
a perfusion solution, and wherein the perfusion solution further comprises:
a metabolic support agent that is selected from the group consisting of glucose, glutamine, and combinations thereof, and that is present in an amount from 0.1 mM to 15 mM;
a membrane stabilizer that is selected from the group consisting of calcium, glycine, chlorpromazine, and combinations thereof and that is present in an amount from 0.1 mM to 10 mM; and
an antioxidant agent selected from the group consisting of beta-carotene, catalase, superoxide dismutase, dimethyl thiourea (DMTU), diphenyl phenylene diamine (DPPD), mannitol, cyanidanol, a-tocopherol, desferoxamine, 6-hydroxy-2,5,7,8-tetramethyl chroman-2-carboxylic acid, and N-acetyl cysteine, and combinations thereof, and that is present in an amount from 0.1 mM to 10 mM.